Esketamine and Magnesium sulfate

PreclinicalSmall molecule

TThe Second People's Hospital of Huai'an

Esketamine and Magnesium sulfate is one of 16 small molecule programs targeting Laparoscopic Cholecystectomy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Laparoscopic CholecystectomyCompleted

Laparoscopic CholecystectomyPreclinical

Completed

Competition

Competitive Landscape

20 competitors in Laparoscopic Cholecystectomy

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

11 2

Duragesic

CCephalon

Approved

6 3

Kytril

CConrado Roberto Hoffmann Filho

Approved

2 4

Nubain

AAultman Health Foundation

Approved

2 5

Bupivacaine and Dexmedetomidine

KKafrelsheikh University

Phase 3

1 6

Bupivacaine and Fentanyl

WWeill Medical College of Cornell University

Phase 3

1 7

Epsom Salt

FFresenius Kabi USA, LLC

Preclinical

6 8

Spravato

WWim Janssens

Preclinical

1 9

Normodyne

AAlvogen Korea

Preclinical

1 10

Tab. Midazolam

BBenazir Bhutto Hospital, Rawalpindi

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Laparoscopic Cholecystectomy1 trial

Effects of Perioperative Intravenous Infusion Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy: A 2×2 Factorial Randomized Controlled Trial

Completed·TThe Second People's Hospital of Huai'an·Preclinical·NCT07131033·128 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Esketamine and Magnesium sulfate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Esketamine and Magnesium sulfate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Esketamine and Magnesium sulfate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The Second People's Hospital of Huai'an company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TThe Second People's Hospital of Huai'an

Esketamine and Magnesium sulfate

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Laparoscopic Cholecystectomy1 trial

References

Drug Info

Quick Facts

Related News